AR024959A1 - Una composicion farmaceutica liquida basada en paracetamol - Google Patents

Una composicion farmaceutica liquida basada en paracetamol

Info

Publication number
AR024959A1
AR024959A1 ARP000103883A ARP000103883A AR024959A1 AR 024959 A1 AR024959 A1 AR 024959A1 AR P000103883 A ARP000103883 A AR P000103883A AR P000103883 A ARP000103883 A AR P000103883A AR 024959 A1 AR024959 A1 AR 024959A1
Authority
AR
Argentina
Prior art keywords
paracetamol
liquid pharmaceutical
pharmaceutical composition
composition based
solution
Prior art date
Application number
ARP000103883A
Other languages
English (en)
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of AR024959A1 publication Critical patent/AR024959A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una forma de dosificacion farmacéutica líquida que consiste en una solucion, la cual comprende por lo menos el 10% (p/v) de paracetamol en PEG-200 anhidro.
ARP000103883A 1999-07-30 2000-07-27 Una composicion farmaceutica liquida basada en paracetamol AR024959A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI001697A IT1313579B1 (it) 1999-07-30 1999-07-30 Composizione farmaceutica liquida a base di paracetamolo.

Publications (1)

Publication Number Publication Date
AR024959A1 true AR024959A1 (es) 2002-10-30

Family

ID=11383451

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000103883A AR024959A1 (es) 1999-07-30 2000-07-27 Una composicion farmaceutica liquida basada en paracetamol

Country Status (4)

Country Link
AR (1) AR024959A1 (es)
AU (1) AU6565100A (es)
IT (1) IT1313579B1 (es)
WO (1) WO2001008662A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2862872A1 (fr) * 2003-12-02 2005-06-03 Palbian Snc Composition a l'etat aqueux pour l'application perfusable d'un principe actif, notamment pharmacologique tel que le paracetamol.
US9585849B2 (en) 2006-04-17 2017-03-07 The Burlington Hc Research Group, Inc. Broad spectrum antiviral and methods of use
EP1992334A1 (en) * 2007-05-08 2008-11-19 Docpharma NV/SA Storage-stable formulation of oxidation-sensitive phenolic drug, especially paracetamol, comprises aqueous drug solution deoxygenated by a temperature-controlled manufacturing process of the formulation
EP2203165B1 (en) * 2007-08-07 2013-05-22 Stellenbosch University Paracetamol for use in treating glaucoma
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
BR112012031928B1 (pt) * 2010-06-30 2021-08-31 Troikaa Pharmaceuticals Ltd Composições farmacêuticas as quais incluem paracetamol e processo para preparação do mesmo
IT1403660B1 (it) * 2011-01-28 2013-10-31 Abiogen Pharma Spa Composizione farmaceutica liquida contenente paracetamolo
WO2015023675A2 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US20150141518A1 (en) * 2013-11-21 2015-05-21 Emphascience, Inc. Water-miscible stable solution composition for pharmaceutically active ingredients that are poorly soluble in water and susceptible to chemical degradation
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
CA2955229C (en) 2014-07-17 2020-03-10 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
JP2017531026A (ja) 2014-10-20 2017-10-19 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド 徐放性乱用抑止性液体充填剤形
US20160144033A1 (en) * 2014-11-21 2016-05-26 Emphascience, Inc. Concentrated acetaminophen solution
PE20171305A1 (es) 2014-12-20 2017-09-05 Troikaa Pharmaceuticals Ltd Formulaciones inyectables de paracetamol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US5505961A (en) * 1993-08-05 1996-04-09 R. P. Scherer Corporation Gelatin capsules containing a highly concentrated acetaminophen solution
US5510389A (en) * 1994-03-02 1996-04-23 The Procter & Gamble Company Concentrated acetaminophen solution compositions
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation

Also Published As

Publication number Publication date
ITMI991697A0 (it) 1999-07-30
WO2001008662A1 (en) 2001-02-08
ITMI991697A1 (it) 2001-01-30
AU6565100A (en) 2001-02-19
IT1313579B1 (it) 2002-09-09

Similar Documents

Publication Publication Date Title
AR024959A1 (es) Una composicion farmaceutica liquida basada en paracetamol
PT1318791E (pt) Composicao farmaceutica semi-solida de isotretinoina
RS54275B1 (sr) Vodeni 2,6-diizopropilfenol farmaceutski sastavi
CO5580776A2 (es) Formulacion farmaceutica estable en solucion de oxaliplatino
PA8509001A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
DE60019693D1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
HK1080364A1 (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability
PA8508701A1 (es) Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco
MXPA02007915A (es) Mediador de lipido activado por aspirina.
EP0221732A3 (en) Sustained release tablets
ES2060825T3 (es) Un sistema terapeutico para el administracion retardada y controlada de sustancias activas por via percutanea o a traves de la mucosa.
NO954320D0 (no) Lyosfærer omfattende gonadotropin
AR028727A1 (es) Una composicion detergente liquida
BR0013106A (pt) Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido.
DE60223542D1 (de) Zusammensetzung mit fulvestrant
CO5570681A2 (es) Formulaciones de jarabe de ribavirina
CO4950520A1 (es) Formulaciones parenterales de 5h-dibenz (b,f) azepin-5- carboxiamidas utiles en el tratamiento de ataques epilepti- cos
ATE338567T1 (de) Pharmazeutische zubereitungen, wirkstoffe enthaltend, die sich für unerlaubte verabreichung anbieten
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
ATE263547T1 (de) Pharmazeutische mischung, die ein profen und weitere aktivsubstanzen enthält
IT1263222B (it) Composizione farmaceutica per la somministrazione attraverso le mucose.
EA200400382A1 (ru) Применение специфической дозы фондапаринукса натрия для лечения окс
GB0128071D0 (en) Medicament
ITRM20020357A1 (it) Composizione liquida per la somministrazione orale di lorazepam.
ES2190267T3 (es) Recipiente de plastico que contiene formulaciones de farmacos estabilizadas.